Introduction: Over the past decade. we have moved on from a predominantly morphological and clinical classification of myeloproliferative neoplasms (MPN) to a more evolved classification that accounts for the molecular heterogeneity that is unique to this subgroup of hematological malignancies. This usually incorporates mutations in Janus kinase 2 (JAK2). MPL. https://pzicyxkjyev73.timeblog.net/70683211/efek-ketergantungan-remaja-k-popers-terhadap-media-sosial-di-kota-palu